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Abstract
Using a neuron-specific retrograde gene-transfer vector (NeuRet vector), we established immunotoxin (IT)-mediated tract
targeting in the primate brain that allows ablation of a neuronal population constituting a particular pathway. Here, we
attempted selective removal of the cortico-subthalamic ‘‘hyperdirect’’ pathway. In conjunction with the direct and indirect
pathways, the hyperdirect pathway plays a crucial role in motor information processing in the basal ganglia. This pathway
links the motor-related areas of the frontal lobe directly to the subthalamic nucleus (STN) without relay at the striatum. After
electrical stimulation in the motor-related areas such as the supplementary motor area (SMA), triphasic responses consisting
of an early excitation, an inhibition, and a late excitation are usually detected in the internal segment of the globus pallidus
(GPi). Several lines of pharmacophysiological evidence suggest that the early excitation may be derived from the
hyperdirect pathway. In the present study, the NeuRet vector expressing human interleukin-2 receptor a-subunit was
injected into the STN of macaque monkeys. Then, IT injections were made into the SMA. In these monkeys, single-neuron
activity in the GPi was recorded in response to the SMA stimulation. We found that the early excitation was largely reduced,
with neither the inhibition nor the late excitation affected. The spontaneous firing rate and pattern of GPi neurons remained
unchanged. This indicates that IT-mediated tract targeting successfully eliminated the hyperdirect pathway selectively from
the basal ganglia circuitry without affecting spontaneous activity of STN neurons. The electrophysiological finding was
confirmed with anatomical data obtained from retrograde and anterograde neural tracings. The present results define that
the cortically-driven early excitation in GPi neurons is mediated by the hyperdirect pathway. The IT-mediated tract targeting
technique will provide us with novel strategies for elucidating various neural network functions.
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Introduction
To define the framework of complex and elaborate neural
networks, it is essential to systematically understand diverse brain
functions acquired on network basis. For elucidating the functional
role of a given pathway, it is an effective approach to examine
behavioral/physiological deficits due to ablation of a neuronal
population that forms the target pathway. Cell targeting mediated
by immunotoxin (IT) has been developed in mice as a genetic
method for ablating distinct types of neurons from neural networks
and applied to identify their specific roles [1–3]. Recently, we have
found that the use of modified glycoprotein of rabies virus for
a pseudotyped lentiviral vector based on human immunodeficien-
cy virus type 1 (HIV-1) can enhance the efficiency of gene transfer
through retrograde transport of the vector [4,5]. This property of
the pseudotyped vector is greatly meritorious for gene transfer into
cell bodies of neurons that are located remote from the injection
site of the vector. For IT-mediated targeting of a particular
pathway, the highly-efficient retrograde gene-transfer vector was
prepared to express human interleukin-2 receptor a-subunit (IL-
2Ra), a receptor molecule for the recombinant IT, in neuronal cell
bodies through retrograde transport of the vector. In mice with the
vector expressing IL-2Ra injected into the striatum, IT injection
into the thalamus indeed succeeded in selective removal of the
thalamostriatal pathway [6].
We applied the IT-mediated tract targeting technique to the
primate brain, because the use of nonhuman primates as animal
models is crucial for exploring higher brain functions. Utilizing the
dopaminergic nigrostriatal pathway as a test system, we have
recently established the basic methodology with a neuron-specific
retrograde gene-transfer vector (NeuRet vector) that we have
newly developed with improved neuronal specificity [7]. By
injecting the NeuRet vector expressing IL-2Ra and IT respectively
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we anatomically verified the validity of the tract targeting
technique [8]. In the present study, an attempt was made to
eliminate the cortico-subthalamic ‘‘hyperdirect’’ pathway selec-
tively from the basal ganglia circuitry in macaque monkeys (for the
hyperdirect pathway, see Refs. 9,10). The subthalamic nucleus
(STN) receives input from the cerebral cortex, especially from the
motor-related areas of the frontal lobe and, in turn, sends output to
the internal segment of the globus pallidus (GPi), a major output
station of the basal ganglia [9–15]. It has been shown that
electrical stimulation in the motor-related areas, including the
primary motor cortex (MI) and the supplementary motor area
(SMA), induces an early, short-latency excitation in GPi neurons,
followed by an inhibition and then a late, long-latency excitation
[10,16,17]. Based on several pharmacophysiological findings, the
early excitation is considered to be derived from the cortico-STN-
GPi pathway [10,16,17], although no direct evidence has as yet
been available. Employing IT-mediated tract targeting, we
addressed the issue on the contribution of this hyperdirect
pathway to the emergence of the early excitation.
Materials and Methods
Viral Vector Production
The details of the NeuRet vector were described in our previous
paper [7]. The NeuRet vector is a pseudotype of an HIV-1-based
lentiviral vector with fusion glycoprotein C type (FuG-C), in which
a short C-terminal segment of the extracellular domain and the
transmembrane/cytoplasmic domains of rabies virus glycoprotein
are replaced with the corresponding regions of vesicular stomatitis
virus glycoprotein. The NeuRet vector enhances the efficiency of
retrograde gene transfer into neuronal cells with less efficiency of
gene transduction into dividing cells in the brain. The envelope
plasmid contained FuG-C cDNA under the control of cytomeg-
alovirus enhancer/chicken b-actin promoter. The transfer plas-
mids contained the cDNA encoding IL-2Ra fused to enhanced
green fluorescent protein (IL-2Ra-GFP) downstream of the
murine stem cell virus promoter. DNA transfection and viral
vector preparation were performed as described elsewhere [7].
HEK293T cells were transfected with transfer, envelope, and
packaging plasmids by the calcium phosphate precipitation
method. Viral vector particles were pelleted by centrifugation at
6,000 g for 16–18 h and resuspended in 0.1 M phosphate-
buffered saline, pH 7.4 (PBS). The particles were then applied to
a Sepharose Q FF ion-exchange column (GE Healthcare,
Buckinghamshire, UK) in PBS and eluted with a linear 0.0–
1.5 M NaCl gradient. The fractions were monitored at absor-
bance 260/280 nm. The peak fractions containing the particles
were collected and concentrated by centrifugation through
a Vivaspin filter (Vivascience, Lincoln, UK). For determination
of the RNA titer, viral RNA in vector preparations was isolated
with a NucleoSpin RNA virus kit (Clontech, Mountain View, CA),
and the copy number of the RNA genome was determined by
using a Lenti-X qRT-PCR titration kit (Clontech). PCR ampli-
fication was performed on duplicate samples by using a StepOne
real-time PCR system (Applied Biosystems, Tokyo, Japan) under
the following conditions: one cycle of 95uC for 3 min; and 40
cycles of 95uC for 15 s and 54uC for 1 min.
Experimental Animals
Three Japanese monkeys (Macaca fuscata; monkeys M, G, and U)
of either sex weighing 5.5–7.6 kg were used. The experimental
protocols were approved by the Institutional Animal Care and Use
Committees of Primate Research Institute, Kyoto University and
National Institutes of Natural Sciences (Permission Numbers:
2011-013 and 11A125, respectively), and all experiments were
conducted according to the guidelines of the National Institutes of
Health Guide for the Care and Use of Laboratory Animals. All
efforts were made to minimize suffering in accordance with the
recommendations of the ‘‘Guidelines for Care and Use of
Nonhuman Primates’’ (Primate Research Institute, Kyoto Uni-
versity). The monkeys were kept in individual primate cages in an
air-conditioned room where food and water were always available.
Their health conditions, including factors such as body weight and
appetite, were checked daily. Supplementary fruits were provided
daily.
Surgical Procedures
Prior to the experiments, each monkey was trained to sit quietly
in a monkey chair. Under general anesthesia with sodium
pentobarbital (25 mg/kg, i.v.) after sedation with ketamine
hydrochloride (10 mg/kg, i.m.) and xylazine hydrochloride (1–
2 mg/kg, i.m.), the monkeys underwent a surgical operation to fix
their head painlessly in a stereotaxic frame attached to the primate
chair (for details, see [16]). Magnetic resonance imaging (3T;
Allegra, Siemens, Erlangen, Germany) scans were performed to
estimate stereotaxic coordinates of the target brain structures (i.e.,
the GPi and STN).
After full recovery from the operation, the skull over the SMA
was removed under light anesthesia with ketamine hydrochloride
(10 mg/kg, i.m.) and xylazine hydrochloride (1–2 mg/kg, i.m.).
The forelimb region and the adjacent orofacial and hindlimb
regions of the SMA were identified by means of electrophysiolog-
ical mapping (for details, see [9,16]). A pair of bipolar stimulating
electrodes (made of 200-mm-diameter enamel-coated stainless steel
wires; intertip distance, 2 mm) was inserted into the SMA forelimb
region at the depth of 4 mm (Fig. 1A). In monkey G, the electrodes
were fixed chronically with transparent acrylic resin as avoiding
insertion points for later IT injections into the cortex. In monkeys
M and U, the stimulating electrodes were inserted in each
experimental session. Finally, a rectangular plastic chamber
covering the SMA was fixed onto the skull with acrylic resin.
GPi Neuron Recordings
During the recording sessions, each monkey was in an awake
state and seated in the monkey chair with his/her head restrained.
A glass-coated Elgiloy-alloy microelectrode (0.5–1.5 MV at 1 kHz)
was inserted obliquely (45u from the vertical line in the frontal
plane) into the GPi using a hydraulic microdrive (Fig. 1A; for
details, see [16,17]). In the GPi, the mediodorsal aspect of its
caudal part that receives input from the SMA was mainly explored
[18]. Single neuron activity recorded extracellularly from the
microelectrode was amplified (x 8,000), filtered (100–2,000 Hz)
and displayed on an oscilloscope. The recorded activity was
isolated and converted into digital pulses using a time-amplitude
window discriminator. Responses of GPi neurons to bipolar
electrical stimulation in the SMA (300-ms-duration single mono-
phasic pulse, strength of less than 0.7 mA, at 0.7 Hz) were
analyzed by constructing peri-stimulus time histograms (PSTHs;
bin width of 1 ms; summed for 100 stimulus trials) using
a computer. A typical response of GPi neurons to the SMA
stimulation was a triphasic pattern composed of an early
excitation, an inhibition, and a late excitation [16,17]. Then, the
spontaneous firing of GPi neurons was recorded as digitized spikes
(bin width of 0.5 ms) for 50 s. Neuronal recordings from the GPi
were initially performed before IT injections into the SMA as
a control (Fig. 1B). Then, GPi recordings were resumed later than
two weeks after the IT injections.
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A setup similar to that for GPi neuron recordings was used for
STN mapping. A glass-coated Elgiloy-alloy microelectrode (1.0–
1.5 MV) was inserted vertically into the STN (Fig. 1A). Neuronal
responses to the SMA stimulation were analyzed by construction
of PSTHs. A typical response of STN neurons was a biphasic
pattern composed of an early excitation and a late excitation [16].
By mapping cortically evoked orthodromic responses, the SMA-
recipient territory was identified in the STN, mainly within its
medial aspect (see [9]).
Based on the results of the STN mapping, a tungusten wire
electrode attached to the injection needle of a 10-ml Hamilton
microsyringe was inserted vertically into the medial aspect of the
STN (Fig. 1A). The tip of the needle was confirmed to be located
right in the STN territory that receives input from the SMA,
especially its forelimb representation, by detecting responses
cortically induced through the electrode. Then, the NeuRet vector
expressing IL-2Ra-GFP (NeuRet-IL-2Ra-GFP vector; 3.6610
10
copies/ml) was injected at 2–3 mediolaterally distinct sites (1.5 ml
each) as covering the SMA-recipient territory of the STN
(Fig. 1A,B).
IT Injections into the SMA
Four-to-six weeks after the vector injections when a population
of SMA neurons projecting to the STN was expected to express
IL-2Ra, IT was injected into the SMA forelimb region to ablate
these neurons selectively (Fig. 1A,B). For IT injection, anti-
Tac(Fv)-PE38 was diluted to a final concentration of 30–40 mg/ml
in PBS [19]. The injection needle of a 10-ml Hamilton
microsyringe was inserted perpendicularly to the cortical surface
at the depth of 3–8 mm, and the IT injections were made at
multiple sites (monkeys M and U: 1.0 ml/site, two dorsoventrally
separate sites per track, two tracks; monkey G: 0.5 ml/site, two
dorsoventrally separate sites per track, three tracks).
Figure 1. Schematic representation of the experimental setup and time-course. A: Experimental setup. A pair of bipolar stimulating
electrodes was placed in the forelimb region of the supplementary motor area (SMA). A glass-coated Elgiloy-alloy microelectrode was inserted
obliquely into the internal segment of the globus pallidus (GPi) for extracellular single-unit recording. The NeuRet-IL-2Ra-GFP vector was injected into
the SMA-recipient territory of the subthalamic nucleus (STN) according to the mapping of cortically evoked responses therein. Four-to-six weeks later,
immunotoxin (IT) was injected into the SMA forelimb region. Cd, caudate nucleus; GPe, external segment of the globus pallidus; Put, putamen. B:
Experimental time-course. Neuronal recordings from the GPi in a control condition were performed before the IT injections into the SMA. Later than
two weeks (wks) after the IT injections, GPi recordings were resumed.
doi:10.1371/journal.pone.0039149.g001
Pathway-Selective Targeting in Monkey Brain
PLoS ONE | www.plosone.org 3 June 2012 | Volume 7 | Issue 6 | e39149Tracer Injections
For retrograde neuronal labeling (monkey M), Fluoro-ruby (FR;
Invitorogen, Eugene, OR; 10% aqueous solution) was injected into
the STN while recordings of neuronal responses to the SMA
stimulation. A single injection of 1.0 ml of FR was made to cover
the SMA-recipient territory of the STN. For anterograde tract
tracing (monkeys G and U), multiple injections of biotinylated
dextran amine (BDA; Invitorogen; 3,000 MW; 20% aqueous
solution) were performed into the forelimb region of the SMA
(0.75 ml/site, two dorsoventrally separate sites per track, three
tracks) through a 10-ml Hamilton microsyringe.
Histological Analysis
Four weeks after the tracer injections, the monkeys were deeply
anesthetized with an overdose of sodium pentobarbital (50 mg/kg,
i.v.) and transcardially perfused with PBS, followed by 10%
formalin in 0.1 M phosphate buffer, pH 7.4 (PB). The brains were
removed from the skull, postfixed in the same fresh fixative
overnight, saturated with 30% sucrose in PB at 4uC, and then cut
serially into 50-mm-thick frontal sections on a freezing microtome.
For visualization of immunoreactive signals of FR and NeuN,
a series of every eighth section was immersed in 1% skim milk for
1 h at room temperature and incubated overnight at 4uC with
rabbit anti-tetramethylrhodamine antibody (Invitrogen; diluted at
1:2,000) or mouse monoclonal anti-NeuN antibody (Millipore,
Temecula, CA; diluted at 1:4,000) in PBS containing 0.1% Triton
X-100 and 1% normal goat serum. The sections were then
incubated in the same fresh medium containing biotinylated goat
anti-rabbit/anti-mouse IgG antibody (Vector Laboratories, Bur-
lingame, CA; diluted at 1:200) for 2 h at room temperature,
followed by avidin-biotin-peroxidase complex (ABC Elite, Vector
Laboratories) for 2 h at room temperature. Subsequently, the
sections were reacted for 1565 min in 0.05 M Tris-HCl buffer
(pH 7.6) containing 0.04% diaminobenzidine (DAB), 0.04%
NiCl2, and 0.003% H2O2. For visualization of injected and
transported BDA, a series of sections was incubated in 0.05 M
PBS containing 0.5% Triton X-100 overnight and processed for
the ABC method as described above. Finally, the sections were
mounted onto gelatin-coated glass slides, air-dried, counterstained
with 1% Neutral red, and coverslipped. Another series of sections
was Nissl-stained with 1% Cresyl violet.
Images of sections were digitally captured using an optical
microscope equipped with a high-grade charge-coupled device
(CCD) camera (Biorevo, Keyence, Osaka, Japan). The number of
FR-positive neurons in the SMA was counted with a computer-
assisted imaging program (BZ-II, Keyence). Seventeen sections for
the SMA obtained from Monkey M were used for cell counts, and
the average number per section was calculated.
Data Analysis
The responses of GPi neurons to the SMA stimulation were
assessed with PSTHs. The mean value and standard deviation
(SD) of the firing rate during 100 ms preceding the onset of
stimulation were calculated from a PSTH and were considered
a value for a baseline discharge. Changes in the firing rate in
response to the SMA stimulation (i.e., excitation and inhibition)
were judged to be significant if the firing rate during at least two
consecutive bins (2 ms) reached the statistical level of P,0.05 (one
tailed t-test), compared with the baseline discharge. The latency of
each response was defined as the time for the first bin exceeding
this level. Responses were judged to end when two consecutive
bins fell below the significant level. The end point was determined
as the time for the last bin exceeding this level. The amplitude of
each response was defined as the number of spikes during the
significant change minus that of the baseline discharge (i.e., the
area of the response; see the colored area in Fig. 2A). For
population PSTHs, the PSTH of each neuron was smoothed with
a Gaussian window (s=2 ms) and averaged separately for
monkeys and conditions (before and after the IT injections). The
spontaneous firing rate and several measures of the firing pattern
were calculated from 50 s of digitized recordings [20]. For firing
pattern analyses, the following parameters were used: interspike
intervals (ISIs); coefficient of variation (CV), kurtosis and skewness
of ISIs; burst index (a ratio of the mean ISI to the mode ISI) [21];
the percentage of spikes in bursts detected by the Poisson surprise
method (Poisson surprise value .3.0 with base 10; the minimum
number of spikes during bursts was three) [20,22]. In addition, the
spontaneous firing pattern was analyzed by constructing auto-
correlograms (bin width of 0.5 ms) from 50 s of digitized
recordings.
Safety Issues
All experimental procedures were performed in a special
laboratory (biosafety level 2) designed for in vivo virus experiments.
To avoid accidental infection, all investigators wore protective
clothes during experimental sessions in the laboratory. Equipment
was disinfected with 70% ethanol after each experimental session,
and waste was autoclaved before disposal.
Results
The NeuRet-IL-2Ra-GFP vector was injected into the STN of
monkeys M, G, and U based on the results of the electrophys-
iological mapping. Histological examination showed that the
vector injections were successfully made into the STN of monkeys
M and G. In these monkeys, the sites of multiple injections were
located in the medial aspect of the STN that receives major input
from the SMA (Fig. S1A; see [9]). On the other hand, as the vector
injections missed the STN in monkey U, this monkey was used as
a control case.
Cortically Evoked Responses of GPi Neurons
Following the vector injections into the STN, activity of 35 GPi
neurons was recorded in monkeys M (n=15) and G (n=20).
Among them, electrical stimulation in the SMA induced responses
in 13 GPi neurons (monkey M, n=4; monkey G, n=9). The most
popular response pattern was a triphasic response consisting of an
early excitation, a subsequent inhibition, and a late excitation (12/
13; Fig. 2A1) as previously reported in normal monkeys [16,17].
This indicated that the vector injections into the STN did not
affect cortically evoked responses of GPi neurons. Using
immnostaining for the neuronal marker NeuN, we also confirmed
that there was no conspicuous damage to the STN (Fig. S1B).
After IT injections into the SMA, especially its forelimb
region, activity of 72 GPi neurons was recorded in monkeys M
(n=44) and G (n=28). Among them, the SMA stimulation
induced responses in 31 GPi neurons (monkey M, n=18;
monkey G, n=13). The most popular response (16/31) was
a biphasic pattern, an inhibition followed by a late excitation
without an early excitation (Fig. 2A2). Other response patterns,
such as a triphasic pattern of an early excitation, an inhibition,
and a late excitation (9/31) and a monophasic inhibition (4/31),
were also observed. The amplitude of each component was
compared before and after the IT injections (Table 1). Compared
with a control condition (before the IT injections), the amplitude
of the early excitation was reduced to 12% of the control after
the IT injections (t-test, P,0.01). On the other hand, the
amplitude of the inhibition and the late excitation remained
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decreased with no significant change. In addition, virtually no
alterations were found in the latency of the inhibition (mean 6
SD; before IT, 28.462.2 ms; after IT, 27.363.1 ms) or the late
excitation (before IT, 43.263.1 ms; after IT, 43.764.9 ms), or
the duration of the inhibition (before IT, 8.563.6 ms; after IT,
8.064.7 ms) or the late excitation (before IT, 17.068.2 ms; after
IT, 15.968.5 ms). The amplitude change in the early excitation
was further detected in population histograms (Fig. 3A,B). In
monkeys M and G, the amplitude of the early excitation was
greatly reduced, while the amplitude of the inhibition and the
late excitation remained relatively unchanged. In monkey U in
which no vector injections were made into the STN, activity of
GPi neurons was recorded before (n=17) and after (n=19) the
IT injections. Among them, nine neurons before the IT
injections and 10 neurons after the IT injections responded to
the SMA stimulation. The most popular response was a triphasic
pattern of an early excitation, an inhibition, and a late excitation
both before (7/9) and after (9/10) the IT injections into the
SMA. The amplitude of each component remained intact after
the IT injections (Fig. 3C, Table 1). Thus, the IT injections into
the SMA combined with the NeuRet-IL-2Ra-GFP vector
injections into the STN abolished the cortically evoked early
excitation in the GPi without affecting either the inhibition or the
late excitation.
Spontaneous Activity of GPi Neurons
Furthermore, the spontaneous firing rate and pattern were
compared before and after the IT injections into the SMA. The
spontaneous firing rate (before IT, 45.867.1 Hz, n=13; after IT,
46.6612.9 Hz, n=31) was left intact (Table 2). Other parameters,
such as ISIs, CV, kurtosis and skewness of ISIs, burst index, and
the percentage of spikes in bursts, did not show any significant
changes (Table 2). Neurons in the GPi fired randomly at high
frequency before the IT injections (Fig. 2B1), and no apparent
changes were observed after the IT injections (Fig. 2B2). These
results suggested that the firing rate and pattern of GPi neurons
remained unchanged even after the removal of the cortico-STN
projection.
Figure 2. Effects on GPi neuron responses of selective elimination of the cortico-STN projection. A: Typical examples of peri-stimulus
time histograms (PSTHs; bin width of 1 ms, summed for 100 stimulus trials) in monkey G before (1) and after (2) IT injections into the SMA. Electrical
stimulation in the SMA was given at time =0 (arrows). In each PSTH, the mean firing rate and statistical levels of P,0.05 (one-tailed t-test) calculated
from the firing rate during 100 ms preceding the onset of SMA stimulation are indicated by the solid white line (mean), broken black line (upper limit
of P,0.05), and broken white line (lower limit of P,0.05), respectively. The excitatory and inhibitory responses are represented in red or cyan color,
respectively. The amplitude of each response was defined as the number of spikes in the colored area. B: Typical examples of spontaneous activities
denoted by slow traces of digitized spikes and autocorrelograms (bin width of 0.5 ms) in monkey G before (1) and after (2) IT injections into the SMA.
doi:10.1371/journal.pone.0039149.g002
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In monkeys M and G subjected to the disappearance of the
early excitation responding to the SMA stimulation, retrograde
and anterograde neural tracings were performed through injecting
FR into the STN and BDA into the SMA. After the FR injection
into the STN (monkey M), retrogradely labeled neurons in the
SMA were much fewer in the forelimb region where the IT
injections were primarily directed than in the orofacial and
hindlimb regions (Fig. 4A,B). Moreover, immnostaining for NeuN
revealed that the IT injections into the SMA caused no marked
neurotoxic insult (Fig. 4C). After the BDA injections into the SMA
forelimb region (monkey G), anterogradely labeled axon terminals
were so largely decreased in the STN (Fig. 4D, right), as compared
to the control case, monkey U (Fig. 4D, left). In remarkable
contrast, dense terminal labeling from the SMA was seen in the
striatum, especially the putamen, as in the control case (Fig. 4E).
These anatomical data clearly indicated that cortico-STN pro-
jection originating from the SMA forelimb region was selectively
eliminated without affecting either the corticostriatal projection or
the cortico-STN projections from SMA regions with other
representations than the forelimb.
Since the present study was primarily designed to develop
a new methodology for selective removal of a given pathway, no
behavioral alterations induced by the elimination of the cortico-
Figure 3. Population histograms of GPi neuron responses. Data obtained before (blue lines) and after (red lines) IT injections into the SMA in
monkey M (A; before IT, n=4; after IT, n=18), monkey G (B; before IT, n=9; after IT, n=13), and monkey U (C; before IT, n=9; after IT, n=10). The
light shaded colors represent 61 SD. A,B: The early excitation was diminished without either the inhibition or the late excitation affected. C: Control
case without vector injections into the STN. No apparent changes were observed after the IT injections into the SMA.
doi:10.1371/journal.pone.0039149.g003
Table 1. Amplitude of cortically-induced triphasic responses
(early excitation, inhibition, and late excitation) of GPi neurons
before and after IT injections into the SMA.
Before IT After IT
Early excitation Monkey M 2246123 (n=4) 24647* (n=18)
Monkey G 7886185 (n=9) 1426178* (n=13)
Monkey U
C 4356222 (n=9) 3686223 (n=10)
Inhibition Monkey M 23366280 23796280
Monkey G 24146227 24196311
Monkey U
C 24236352 25106239
Late excitation Monkey M 4936170 4026635
Monkey G 22286903 158061148
Monkey U
C 11446845 10276879
Each value represents the mean 6 SD expressed in the number of spikes during
the significant change minus that of the baseline discharge (see Fig. 2A).
*Significant decrease in comparison with data obtained before IT injections
(P,0.01, t-test).
CUsed as control.
doi:10.1371/journal.pone.0039149.t001
Table 2. Firing patterns of GPi neurons before and after IT
injections into the SMA.
Before IT After IT
Firing rate (Hz) Monkey M 52.964.7 (n=4) 49.4614.0
(n=18)
Monkey G 41.764.4 (n=9) 39.966.3 (n=13)
Monkey U
C 47.268.8 (n=9) 42.8610.7
(n=10)
ISI (ms) Monkey M 15.961.2 21.765.7
Monkey G 24.262.5 25.663.8
Monkey U
C 21.964.2 24.765.9
CV of ISI Monkey M 1.160.2 1.360.5
Monkey G 1.560.9 1.360.2
Monkey U
C 1.160.3 1.560.8
Kurtosis of ISI Monkey M 36.1647.8 70.3689.1
Monkey G 61.3655.8 36.7618.5
Monkey U
C 40.3650.0 66.1663.6
Skewness of ISI Monkey M 4.262.9 5.663.6
Monkey G 5.863.5 4.461.1
Monkey U
C 4.062.7 6.765.1
Busrt index Monkey M 5.263.1 3.962.4
Monkey G 2.760.8 3.161.6
Monkey U
C 4.862.7 3.162.7
Percentage of spikes in
bursts (%)
Monkey M 3.261.0 4.762.7
Monkey G 4.464.1 6.264.7
Monkey U
C 2.561.6 3.962.3
Each value represents the mean 6 SD.
No significant changes were detected in comparison with data obtained before
IT injections (P,0.01, t-test).
CUsed as control.
doi:10.1371/journal.pone.0039149.t002
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PLoS ONE | www.plosone.org 6 June 2012 | Volume 7 | Issue 6 | e39149Figure 4. Retrograde and anterograde neural tracings. A: Retrograde neuronal labeling in the orofacial and forelimb regions of the SMA after
Fluoro-ruby (FR) injection into the STN in monkey M. Lower panels a,b denote higher-power magnifications of the rectangular areas in upper panels.
Scale bars, 500 mm for upper panels and 200 mm for lower panels. B: Distribution of FR-positive neurons in the orofacial (OF), forelimb (FL), and
hindlimb (HL) regions of the SMA. Cell counts were carried out in 17 equidistant frontal sections taken from Monkey M. Note that FR-positive neurons
are so few in the FL region where IT injections were made (at two rostrocaudally distinct levels pointed to by arrows), as compared to those in the OF
and HL regions. Numerals on the abscissa represent the distance from rostrocaudal zero on the stereotaxic frame (equivalent to the interaural line). C:
NeuN immunostaining of the orofacial and forelimb regions of the SMA. Note that the IT injections cause no marked neurotoxic insult. Scale bars,
500 mm. D: Anterograde terminal labeling in the STN after BDA injections into the SMA forelimb region. Left: monkey U without vector injections into
the STN. Right: monkey G with vector injections into the STN. Note that BDA-labeled axon terminals are much less densely observed in the STN after
the IT injections into the SMA combined with the vector (IL-2Ra) injections into the STN. Scale bars, 50 mm. E: Terminal labeling in the putamen in
monkeys U (left) and G (right). Note that virtually no difference in the density of labeled terminals is found between the two cases. ic, internal capsule.
Scale bars, 50 mm.
doi:10.1371/journal.pone.0039149.g004
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motor deficits were observed in either monkey M or monkey G.
Discussion
Taking advantage of the NeuRet vector that permits highly-
efficient retrograde gene-transfer with improved neuronal spec-
ificity [7], we established IT-mediated tract targeting in the
primate brain. In the present study, we applied this pathway-
selective targeting technique to the hyperdirect pathway.
Together with the direct and indirect pathways (for reviews,
see [23,24]), the hyperdirect pathway is known to be among the
major pathways of the basal ganglia [9,10]. This pathway
connects the motor-related areas of the frontal lobe to the GPi,
an output station of the basal ganglia, at short latency via the
STN without relay at the striatum and is involved in motor
information processing in the basal ganglia. When single neuron
activity was recorded in the monkey GPi in response to electrical
stimulation in the motor-related areas, such as the MI and SMA,
triphasic responses consisting of an early (short-latency) excita-
tion, an inhibition, and a late (long-latency) excitation were
obtained. It has been suggested that the early excitation may be
derived from the cortico-STN-GPi hyperdirect pathway based on
the following pharmacophysiological data (see also [10]): (1)
Blockade of STN neuron activity by injection of the GABAA
receptor agonist, muscimol, thereinto abolished the early as well
as the late excitation of GPi neurons [16]; (2) Blockade of
glutamatergic input from the STN to the GPi by local injection
of an ionotropic glutamatergic receptor antagonist diminished
the early as well as the late excitation of GPi neurons [17].
However, these approaches concurrently decreased the firing rate
of GPi neurons and changed their firing pattern from a random
to a bursting and/or oscillatory one.
For selective removal of the hyperdirect pathway, the NeuRet-
IL-2Ra-GFP vector was injected into the STN, and, subsequently,
IT was injected into the SMA in the present experiments. Our
histological examination clearly indicated that cortical neurons in
the forelimb region of the SMA projecting to the STN were
selectively ablated. In such model monkeys, neuronal activity in
the GPi was recorded in response to electrical stimulation in the
SMA. The SMA stimulation results in selective activation of SMA-
recipient zones in the basal ganglia [25]. We found that out of the
triphasic responses, only the early excitation was largely
suppressed with the inhibition or the late excitation virtually
unaffected. This indicates that IT-mediated tract targeting
successfully eliminated the hyperdirect pathway selectively from
the basal ganglia circuitry. The present results define that the
cortically-driven early excitation of GPi neurons is derived from
the cortico-STN projection. It has also been revealed in the
present study that the firing rate and pattern of GPi neurons
remain unchanged even after the removal of the cortico-STN
projection. This implies that the cortico-STN projection conveys
phasic activity changes from the SMA to the GPi, but does not
contribute to maintenance of tonic activity of GPi neurons. In
contrast to the early excitation, the inhibition in the GPi was not
affected by the elimination of the cortico-STN projection, as it can
be considered that the inhibition is mediated by the cortico-striato-
GPi direct pathway [17]. On the other hand, the late excitation in
the GPi was slightly diminished though not significant. This late
excitation is ascribable to the late excitation in the STN and is
probably mediated by the cortico-striato-external pallidal segment
(GPe)-STN-GPi indirect pathway. However, it has also been
suggested that the late excitation in the STN is part of the
prolonged excitation induced by the cortico-STN projection,
which may explain a slight decrease in the late excitation in the
GPi after the elimination of the cortico-STN projection [17].
According to the cortically-induced triphasic response pattern
detected in GPi neurons, the hyperdirect pathway conveys
excitatory signals from the frontal motor-related areas toward
the GPi, bypassing the striatum, with shorter conduction time than
signals through the striatum that arise from both the direct and the
indirect pathways (see [10,16]). In favor of a dynamic ‘‘center-
surround model’’ of basal ganglia function that was first proposed
by Mink and Thach [12], we have implicated the functional role of
the hyperdirect pathway in the control of voluntary limb
movements (see also [10,14,26]). When a voluntary movement is
about to be initiated by the motor cortical mechanism, a corollary
signal conveyed through the cortico-STN-GPi hyperdirect path-
way first inhibits large areas of the thalamic and cortical target
structures that are involved not only in a desired motor program,
but also in other competing programs. Then, another corollary
signal through the cortico-striato-GPi direct pathway disinhibits
part of the thalamic and cortical target areas and releases the
desired motor program alone. Finally, the third corollary signal
transmitted by way of the cortico-striato-GPe-STN-GPi indirect
pathway again inhibits the thalamic and cortical target areas
extensively. By means of such sequential motor information
processing, only the desired motor program is initiated, executed,
and terminated at appropriate timings, whereas other competing
programs are canceled. Thus, it is most likely that the hyperdirect
pathway exerts a powerful excitatory effect on the GPi to suppress
involuntary and unnecessary movements prior to the selected
motor action. The following works favor this notion: (1) Lesions or
blockade of STN neuron activity induced involuntary movements,
hemiballism [16,27,28], suggesting that both the hyperdirect and
indirect pathways might inhibit unnecessary movements; (2)
According to functional magnetic resonance imaging studies using
human subjects, the cortico-STN projection conveys stop signals
to inhibit motor responses [29,30]; (3) It is also suggested that the
cortico-STN projection may inhibit automatic movements and
switch to volitionally controlled movement [31]. In the present
experiments, however, no apparent behavioral changes were
observed in our model monkeys subject to the IT-mediated
selective removal of the hyperdirect pathway. Some specific motor
task to be trained in these model monkeys may be required to
disclose motor impairments.
The IT-mediated tract targeting achieves selective elimination
of given pathways in monkeys as well as in rodents. This novel
technique will provide a general, powerful strategy to investigate
precisely not only the specific functional roles of individual
pathways constituting a particular neural network, but also the
large-scale operative mechanisms underlying the entire network.
Supporting Information
Figure S1 Frontal sections showing injection site of the
NeuRet-IL-2Ra-GFP vector in the STN. A: GFP immunos-
taining. B: NeuN immunostaining. Note that the vector injections
were placed in the medial aspect of the STN where major input
from the SMA terminates, and that there is no conspicuous
damage to the STN. cp, cerebral peduncle; ot, optic tract; ZI, zona
incerta. Right side, medial; upper side, dorsal. Scale bar, 1 mm.
(TIF)
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